Lifestyle interventions and physical activity

Researchers have established a dose–response effect of exercise on glucose metabolism in people with type 2 diabetes who are dieting for weight loss.

There is a “substantial” burden of overweight and obesity among people with type 1 diabetes, say US researchers who found rates to be in line with that of the general population.

Real-world data from the UK Biobank show the value of a healthy lifestyle in people with type 2 diabetes hoping to avoid microvascular complications.

Blood glucose falls further when people with type 1 diabetes run than when they cycle, show the findings of a systematic review and meta-analysis.

Findings from the HIT4HYPOS trial suggest that a high-intensity exercise program may improve hormonal and symptomatic responses to hypoglycemia among people with type 1 diabetes and impaired awareness of hypoglycemia.

Starting treatment with SGLT2 inhibitors, GLP-1 receptor agonists, or DPP-4 inhibitors is associated with a reduction in physical activity levels among some people with type 2 diabetes, researchers report.

Lifestyle intervention proves “highly successful” in adults with diabetes aged 65 to 85 years, improving both metabolic and functional health, report researchers.

A family history of diabetes is associated with a younger age at type 2 diabetes diagnosis, but this could be delayed by following a healthy lifestyle, suggest data from the Joint Asia Diabetes Evaluation Register.

Even small increases in the number of steps taken in a day is associated with a reduced risk for mortality in people with prediabetes or diabetes, say researchers.

Fluctuations in blood glucose levels during the night can adversely impact the psychologic and physical function of people with type 1 diabetes during the following day, report researchers.

People with impaired glucose tolerance who received metformin or intensive lifestyle intervention during the DPP trial show no sign of a significantly reduced cardiovascular disease risk 21 years later, reveal the latest DPPOS results.

Fewer than one in 10 people with type 2 diabetes in low- and middle-income countries receive treatment in line with World Health Organization recommendations, shows a global analysis.

A randomized trial supports giving people with obesity liraglutide to maintain weight loss after an 8-week diet, particularly if it is combined with regular vigorous exercise.

Findings from a modeling study suggest that community-based exercise and cognitive behavioral therapy interventions for depression in people with type 2 diabetes are cost-effective in the long-term.

A dog with diabetes may be a novel early warning sign for diabetes risk in its owner, according to a study in the Christmas edition of The BMJ.

People with type 2 diabetes have around a fourfold increased risk for heart disease relative to those without, but having a healthy lifestyle may lessen this risk, researchers report.

Focusing efforts on convincing people to return after the first session of the US National Diabetes Prevention Program lifestyle change program, and after the transition to less frequent sessions, may help to optimize program retention, say researchers.

Consuming a single shot of fructose prior to exercise is a feasible strategy to reduce the risk for exercise-induced hypoglycemia among men with type 1 diabetes treated with insulin degludec, suggest findings from a proof-of-concept study.

The increased risk for prediabetes among ethnic minorities compared with White people is less pronounced in neighborhoods with high walkability, shows a Canadian study.

A proof-of-concept study indicates that taking some basal insulin as a single injection of degludec improves glucose control during and after exercise in people with type 1 diabetes who prefer to remove their insulin pump while exercising.